Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Belot

Showing results (241-250 of 251) with videos related to

Pageof 26
Sort By:
Human Mutation|January 4, 2020
Genetic and phenotypic spectrum associated with IFIH1 gain-of-functionGillian I Rice, Sehoon Park, Francesco Gavazzi, et al.
Pediatric Rheumatology Online Journal|February 24, 2015
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaborationLakshmi Nandini Moorthy, Elizabeth Roy, Vamsi Kurra, et al.
The Journal of Experimental Medicine|January 4, 2024
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in childrenPaul Bastard, Adrian Gervais, Maki Taniguchi, et al.
Science (New York, N.Y.)|December 20, 2022
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in childrenDanyel Lee, Jérémie Le Pen, Ahmad Yatim, et al.
The Journal of Experimental Medicine|November 22, 2024
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)Evangelos Bellos, Dilys Santillo, Pierre Vantourout, et al.
Science Immunology|July 20, 2022
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNsPaul Bastard, Sara E Vazquez, Jamin Liu, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Nature|November 8, 2023
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiencyTom Le Voyer, Audrey V Parent, Xian Liu, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Paul Bastard, Adrian Gervais, et al.
Pageof 26

Showing results (241-250 of 251) with videos related to

Sort By:
Pageof 26
Human Mutation|January 4, 2020
Genetic and phenotypic spectrum associated with IFIH1 gain-of-functionGillian I Rice, Sehoon Park, Francesco Gavazzi, et al.
Pediatric Rheumatology Online Journal|February 24, 2015
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaborationLakshmi Nandini Moorthy, Elizabeth Roy, Vamsi Kurra, et al.
The Journal of Experimental Medicine|January 4, 2024
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in childrenPaul Bastard, Adrian Gervais, Maki Taniguchi, et al.
Science (New York, N.Y.)|December 20, 2022
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in childrenDanyel Lee, Jérémie Le Pen, Ahmad Yatim, et al.
The Journal of Experimental Medicine|November 22, 2024
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)Evangelos Bellos, Dilys Santillo, Pierre Vantourout, et al.
Science Immunology|July 20, 2022
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNsPaul Bastard, Sara E Vazquez, Jamin Liu, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Nature|November 8, 2023
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiencyTom Le Voyer, Audrey V Parent, Xian Liu, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Paul Bastard, Adrian Gervais, et al.
Pageof 26